Alzai Health Corp. ALZI.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 19.90K | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 19.90K | -- | -- | -- | |
| Cost of Revenue | 302.20K | -- | -- | -- | |
| Gross Profit | -282.30K | -- | -- | -- | |
| SG&A Expenses | 1.53M | -- | -- | -- | |
| Depreciation & Amortization | 12.00K | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 2.67M | -- | -- | -- | |
| Operating Income | -2.65M | -- | -- | -- | |
| Income Before Tax | -2.68M | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -2.68 | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -2.68M | -- | -- | -- | |
| EBIT | -2.65M | -- | -- | -- | |
| EBITDA | -2.65M | -- | -- | -- | |
| EPS Basic | -0.05 | -- | -- | -- | |
| Normalized Basic EPS | -0.03 | -- | -- | -- | |
| EPS Diluted | -0.05 | -- | -- | -- | |
| Normalized Diluted EPS | -0.03 | -- | -- | -- | |
| Average Basic Shares Outstanding | 205.47M | -- | -- | -- | |
| Average Diluted Shares Outstanding | 205.47M | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |